[Treatment of Chagas' disease].
D000818:Animals; D002415:Cats; D014355:Chagas Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006224:Cricetinae; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D051379:Mice; D009547:Nifurtimox / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009581:Nitrofurans / Q000627:therapeutic use*; D009593:Nitroimidazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D014344:Trypanocidal Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014349:Trypanosoma cruzi / Q000187:drug effects
D009581:Nitrofurans; D009593:Nitroimidazoles; D014344:Trypanocidal Agents; D009547:Nifurtimox; C009999:benzonidazole
Tratamiento de la enfermedad de Chagas.